Characterization of [ 3 H]Met‐Enkephalin‐Arg 6 ‐Phe 7 Binding to Opioid Receptors in Frog Brain Membrane Preparations

A tritiated heptapeptide, [ 3 H]Tyr‐Gly‐Gly‐Phe‐Met‐Arg‐Phe ([ 3 H]Met‐enkephalin‐Arg 6 ‐Phe 7 ), with high specific radioactivity has been synthesized in order to characterize its opioid binding activity to frog brain membrane fractions. The apparent K D value of the radioligand calculated from homologous displacement experiments was 3.4 n M , and the maximal number of specific binding sites was 630 fmol/mg of protein. The K D determined from equilibrium saturation binding studies was found to be 3.6 n M . However, the Hill coefficient was far below unity ( n H = 0.43), which suggests the presence of a second, lower affinity binding site. The presence of this binding component is strengthened by the displacement experiments performed with levorphanol and some other ligands. It is assumed that the lower affinity site has no opiate character. The rank order of potency of the applied ligands in competing reversibly with [ 3 H]Met‐enkephalin‐Arg 6 ‐Phe 7 binding reflects a κ 2 ‐ and/or δ‐subtype specificity of the heptapeptide. Binding to a κ 1 and/or μ site of opioid receptors is excluded, but the existence of a novel endogenous opiate receptor subtype for Met‐enkephalin‐Arg 6 ‐Phe 7 in frogs cannot be ruled out. The [ 3 H]Met‐enkephalin‐Arg 6 ‐Phe 7 binding was inhibited by both sodium ions and GppNHp, which suggests the opioid agonist character of the heptapeptide.